Home › Funds › Royce & Associates › ALKS
Royce & Associates position in ALKS
ALKERMES PLC · Health Care
Latest position (Q2 2026)58.07K sh
Reported value held$3.04M
Portfolio Weight0.02%
First reportedQ1 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 31.85K | $862.07K | New |
| Q2 2024 | 45.27K | $1.09M | Add |
| Q3 2024 | 67.63K | $1.89M | Add |
| Q4 2024 | 54.43K | $1.57M | Reduce |
| Q1 2025 | 47.19K | $1.56M | Reduce |
| Q2 2025 | 49.73K | $1.42M | Add |
| Q3 2025 | 49.77K | $1.49M | Hold |
| Q4 2025 | 48.01K | $1.34M | Reduce |
| Q1 2026 | 55.68K | $1.97M | Add |
| Q2 2026 | 58.07K | $3.04M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ALKS
- BlackRock Inc 29.24M sh · $1.53B · Q2 2026
- Vanguard Group 18.01M sh · $503.85M · Q4 2025
- Renaissance Technologies 6.46M sh · $338.52M · Q2 2026
- Geode Capital Management 4.48M sh · $234.66M · Q2 2026
- Wellington Management Group 2.81M sh · $147.48M · Q2 2026
- Charles Schwab Investment Management 2.34M sh · $122.35M · Q2 2026
- Norges Bank Investment Management 2.16M sh · $113.01M · Q2 2026
- Goldman Sachs Group 2.02M sh · $106.05M · Q2 2026
- Citadel Advisors 1.89M sh · $99.13M · Q2 2026
- Northern Trust Corp 1.83M sh · $95.97M · Q2 2026
- Morgan Stanley 1.75M sh · $91.79M · Q2 2026
- D. E. Shaw & Co 1.31M sh · $68.74M · Q2 2026